Brainstorm Cell Therapeutics Inc. (BCLI) Social Stream



Brainstorm Cell Therapeutics Inc. (BCLI): $3.08

-0.06 (-1.91%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BCLI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 504

in industry

Brainstorm Cell Therapeutics Inc (BCLI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Brainstorm Cell Therapeutics Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2 $12 $11 $11.5 $3.14 266.24%

The Trend in the Analyst Price Target


BCLI's average price target has moved down $2 over the prior 16 months.

BCLI reports an average of 248.8% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 2 12.0 11.0 11.50 3.40 238.24%
2021-09-19 2 12.0 11.0 11.50 3.53 225.78%
2021-09-18 2 12.0 11.0 11.50 3.53 225.78%
2021-09-11 2 12.0 11.0 11.50 3.28 250.61%
2021-09-04 2 12.0 11.0 11.50 3.46 232.37%
2021-07-29 2 12.0 11.0 11.50 3.52 226.7%
2021-05-26 2 12.0 11.0 11.50 3.61 218.56%
2021-05-22 2 12.0 11.0 11.50 3.51 227.64%
2021-05-15 2 12.0 11.0 11.50 3.38 240.24%
2021-05-08 2 12.0 11.0 11.50 3.17 262.78%
2021-04-25 2 12.0 11.0 11.50 3.46 232.37%
2020-12-04 2 33.0 25.0 29.00 5.77 402.6%
2020-11-28 2 33.0 25.0 29.00 5.25 452.38%
2020-10-15 2 25.0 20.0 22.50 15.29 47.16%
2020-09-21 1 20.0 20.0 20.00 NA NA%
2020-09-18 1 20.0 20.0 20.00 NA NA%
2020-08-15 2 20.0 17.5 18.75 NA NA%
2020-07-08 3 20.0 14.0 17.17 NA NA%
2020-06-10 3 17.5 9.0 13.50 NA NA%

BCLI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.75 0 1 1 0 0 2

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The upside potential (average analyst target price relative to current price) of BCLI is higher than 92.51% of all US stocks.
  • BCLI has a higher number of analysts covering the stock than 16.91% of all US stocks.
  • The variance in analysts' estimates of BCLI is less than 82.49% of Pharmaceutical Products stocks.
  • Brainstorm Cell Therapeutics Inc's average analyst price target is higher than 21.71% of all US stocks.

In the Pharmaceutical Products industry, ACER, PTE and CLSN are the three stocks most similar to Brainstorm Cell Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is BCLI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7509 seconds.